Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Cancer Research|April 1, 1991
Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agentsL S Hollis, W I Sundquist, J N Burstyn, et al.
Cellular Microbiology|September 18, 2018
FOXA2 depletion leads to mucus hypersecretion in canine airways with respiratory diseasesWoosuk Choi, Alina X Yang, Michelle A Waltenburg, et al.
Veterinary Anaesthesia and Analgesia|February 12, 2023
Lumbosacral plexus block using a combination of ultrasound-guided lateral pre-iliac and parasacral approaches in catsDiego A Portela, Mariana Cavalcanti, Jorge G Teixeira, et al.
Controlled Clinical Trials|June 1, 1991
Methods, statistical features, and baseline results of a standardized, multicentered ophthalmologic surgical trial: the Silicone StudyS P Azen, D C Boone, W Barlow, et al.
Pediatric Blood & Cancer|March 22, 2016
Unique Familial MLL(KMT2A)-Rearranged Precursor B-Cell Infant Acute Lymphoblastic Leukemia in Non-twin SiblingsKaren A Urtishak, Blaine W Robinson, Eric F Rappaport, et al.
Pathogens (Basel, Switzerland)|May 5, 2021
Sylvatic Canine Morbillivirus in Captive <i>Panthera</i> Highlights Viral Promiscuity and the Need for Better Prevention StrategiesMainity Batista Linhares, Herbert E Whiteley, Jonathan P Samuelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastomaS A Grupp, J W Stern, N Bunin, et al.
Congenital Heart Disease|August 16, 2012
Nutrition algorithms for infants with hypoplastic left heart syndrome; birth through the first interstage periodJulie Slicker, David A Hehir, Megan Horsley, et al.
Pharmaceutical Research|May 5, 1999
Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT)P J Sinko, Y H Lee, V Makhey, et al.
Bone|December 14, 2012
Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosisK Henriksen, J R Andersen, B J Riis, et al.
Pageof 12